Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.

ABSTRACT:

SUBMITTER: Wang X 

PROVIDER: S-EPMC11369195 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature